For example, ER- and ER+ breast cancers show distinct transcriptional profiles and cross-talk occurs with ER [41] ER is able to activate HER2 signalling so HER2 activity may differ between HER2+ basal and luminal tumours [42]. The gene discussed is ERBB2; the disease is breast cancer.